The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Apellis Pharmaceuticals, Inc(NASDAQ:APLS) 
Apellis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. Its lead product candidate is pegcetacoplan that is in Phase III clinical trials fo...
Website: http://www.apellis.com
Founded: 2009
Full Time Employees: 350
Sector: Healthcare
Industry: Biotechnology
Apellis Pharmaceuticals Days Payable Outstanding ttm (DPO)
Apellis Pharmaceuticals Days Receivable Outstanding ttm (DSO)
Apellis Pharmaceuticals Days Inventory Outstanding ttm (DIO)
Apellis Pharmaceuticals Op Cashflow Per Share ttm
Apellis Pharmaceuticals Free Cashflow Per Share ttm
Apellis Pharmaceuticals Cash Per Share ttm
Apellis Pharmaceuticals P/S ratio ttm
Apellis Pharmaceuticals (GAAP) P/E ratio ttm
Apellis Pharmaceuticals P/B ratio ttm
No extra charts and metrics for this ticker.